WEP Clinical has partnered with The Jordan Company
Overview
Deal Type |
Mergers & Acquisitions |
---|---|
Client & Transactional Partners |
WEP Clinical The Jordan Company |
Our Role |
Sell-Side Advisor |
Summary
The Jordan Company, L.P. has completed an investment in WEP Group Holdings Limited. TJC made the investment in partnership with WEP Clinical co-founders Jaswinder Khera and Jaswant Khera who will continue to be significant owners in the business while leading the Company through this next phase of growth.
Cain Brothers and Clearwater International were retained by WEP Clinical to assist the Company through its sales process based on Cain Brothers’ and Clearwater’s strong reputation for exceedingly successful M&A processes and the strong track record of its growing pharma services franchise.
Established in 2008, WEP Clinical is a specialist pharma services company that partners with drug developers to help patients and physicians gain early access to treatments for rare diseases, cancer and other serious or life-threatening illnesses that have no viable treatment options available. The Company is a market leader in the design and execution of expanded access and named patient programs, which provide pre-approval access to promising molecules for patients with critical unmet medical needs. Additionally, WEP Clinical offers real-world data collection, market access services, pharmacovigilance services, patient registry, commercialization services, clinical trial nursing services and comparator sourcing.
TJC, founded in 1982, is a middle-market private equity firm that has managed funds with original capital commitments in excess of $17 billion and a 39-year track record of investing in and contributing to the growth of many businesses across a wide range of industries including Healthcare & Consumer; Industrials; Technology, Telecom & Utilities; and Transportation & Logistics. The senior investment team has been investing together for over 20 years and it is supported by the Operations Management Group, which was established in 1988 to initiate and support operational improvements in portfolio companies.